EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer

BACKGROUND: In various cancers, overexpression of cyclooxygenase (COX)-2 and elevated prostaglandin (PG) E2 synthesis have been associated with tumor development and progression. The potential of COX-2 inhibitors in cancer prevention and treatment has been shown repeatedly; however, their clinical u...

Descripción completa

Detalles Bibliográficos
Autores principales: Semmlinger, Anna, von Schoenfeldt, Viktoria, Wolf, Verena, Meuter, Alexandra, Kolben, Theresa Maria, Kolben, Thomas, Zeder-Goess, Christine, Weis, Florian, Gallwas, Julia, Wuerstlein, Rachel, Hermelink, Kerstin, Schmoeckel, Elisa, Harbeck, Nadia, Mayr, Doris, Mahner, Sven, Jeschke, Udo, Ditsch, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902996/
https://www.ncbi.nlm.nih.gov/pubmed/29661238
http://dx.doi.org/10.1186/s12885-018-4286-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902996/
https://www.ncbi.nlm.nih.gov/pubmed/29661238
http://dx.doi.org/10.1186/s12885-018-4286-9

Ejemplares similares